IL6 and Alzheimer disease: The chronic neuroinflammation in AD is further characterized by proinflammatory biochemical processes, including the release of proinflammatory cytokines, mainly interleukin-1β (IL-1β), tumor necrosis factor alpha (TNF-α), and IL-6 (35).